U.S. Markets open in 1 hr 16 mins

Danaher Corporation (DHR)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
251.80+2.49 (+1.00%)
At close: 04:04PM EDT
251.80 0.00 (0.00%)
After hours: 07:47PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close249.31
Bid246.33 x 800
Ask251.03 x 1000
Day's Range246.35 - 254.50
52 Week Range233.71 - 333.96
Avg. Volume2,788,021
Market Cap179.93B
Beta (5Y Monthly)0.78
PE Ratio (TTM)31.95
EPS (TTM)7.88
Earnings DateApr 20, 2022 - Apr 25, 2022
Forward Dividend & Yield1.00 (0.40%)
Ex-Dividend DateJun 23, 2022
1y Target Est327.80
  • Simply Wall St.

    Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

    Danaher Corporation ( NYSE:DHR ) saw significant share price movement during recent months on the NYSE, rising to highs...

  • Insider Monkey

    10 Defensive ETFs to Buy Before Recession

    In this article, we discuss 10 defensive ETFs to buy before recession. If you want to read about some more defensive ETFs, go directly to 5 Defensive ETFs to Buy Before Recession. Sometimes, the best offense is a good defense. This is certainly the case at the stock market these days as inflation and rising […]

  • PR Newswire

    Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases

    Danaher Corporation (NYSE: DHR) announced that it has joined the Bespoke Gene Therapy Consortium (BGTC). Launched in October 2021, the BGTC will generate gene therapy resources that the research community can use to streamline gene therapy development for rare disorders, making the process more efficient and less costly. Danaher's Life Science companies join the Food and Drug Administration (FDA), the National Institutes of Health (NIH), twelve pharmaceutical and biotech companies and nine non-p